Jaguar Animal Health (JAGX) Updates on Equilevia Dose Determination Study in Horses; Higher Avg. Winnings Noted StreetInsider.com Jaguar Animal Health, Inc. (Nasdaq: JAGX) issued a summary of racing data for horses taking part in the Company's recently completed dose determination study of the target commercial paste formulation of Equilevia (formerly referred to as SB-300), the ... |
-
-
Featured
- Claiming Crown: Laughing Boy Awarded Win In Jewel Via Disqualification – Paulick Report
- 70 Ranch Announces Retirement of Top Futurity Horse and NFR Qualifier – Sports Illustrated
- Cornell’s Equine Seminar Series Presents “Behavior Medication Considerations for Horses” – FTBOA
- Have you seen “High Horse”? – Scarlet and Black
- Tim Yakteen-Trained Practical Dream Denies Bob Baffert’s Trio In Desi Arnaz – Paulick Report
Comments
- Ruth on Houston SPCA to seek custody of 8 horses rescued from Brookshire property – KTRK-TV
- Ed on With Hurricane Florence on the way, some horses go while others stay – Virginian-Pilot
- edward on Arizona Hay Report: November 09, 2018
- edward on Shop Arizona Hay
- Vicki Wells on Open to the public: Monty Roberts’ ‘The Movement 2018’ brings equine experts to Solvang – Manhattan Mercury
